Published in Lab Law Weekly, July 6th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Alpharma Inc..
Report 1: Alpharma Inc. (NYSE:ALO), a leading global specialty pharmaceutical company through its Pharmaceuticals Division, this week presented positive results of a pharmacokinetic study of its investigational abuse-deterrent, extended-release opioid at the 26th annual scientific meeting of the American Pain Society in Washington, D.C. The data demonstrated the release characteristics of this extended-release morphine sulfate plus sequestered naltrexone product were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.